For years, hypertension has dominated the health care field, afflicting 45 percent of all adult Americans. Another disease that has gained renown in the world of health care is diabetes, afflicting 10.5 percent of the U.S. population.
Health care professionals have allocated untold assets to minimize the impact such diseases pose. Yet, the relative obscurity and lack of funding towards combating chronic kidney disease (CKD) is ironic, considering its impact on the world’s population.
CKD’s progressive loss of kidney function results in total kidney failure and end-stage renal disease (ESRD). CKD is an ailment that afflicts 15 percent of all adults in the U.S. and a staggering connection to hypertension and diabetes, the two leading causes of CKD, with hypertension being of clinically significant note for care providers.